Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain a and integrin α9

Journal of Cellular Biochemistry

Volumn 112, Issue 8, 2011, Pages 2106-2114

  Ou, Juanjuan ^a   Li, Jianjun ^a   Pan, Feng ^a   Xie, Ganfeng ^a   Zhou, Qi ^a   Huang, Haihui ^a   Liang, Houjie ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Eda integrin 9; Endostatin; Lymphangiogenesis

Indexed keywords

ALPHA9 INTEGRIN; FIBRONECTIN; FIBRONECTIN EXTRA DOMAIN A; INTEGRIN; RECOMBINANT ENDOSTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MEMBRANE; CELL POLARITY; CHEMOTAXIS; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSKELETON; DRUG EFFECT; DRUG INHIBITION; GENE EXPRESSION; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOFLUORESCENCE MICROSCOPY; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; COLORECTAL NEOPLASMS; ENDOSTATINS; ENDOTHELIAL CELLS; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MULTIPROTEIN COMPLEXES; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 79960341070     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23130     Document Type: Article

References (23)

1. Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W, Folkman J, Hlatky L, Huber PE,. 2004. Endostatin's antiangiogenic signalling network. Mol Cell 13: 649-663.
2. Achen MG, Stacker SA,. 2008. Molecule control of lymphatic metastasis. Ann NY Acad Sci 1131: 225-234.
3. Achen MG, McColl BK, Stacker SA,. 2005. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7: 121-127. (Pubitemid 40248338)
4. Arti VS, Christopher B, Chunyu W, Mariette GV, Peter VA, Richard O,. 2008. Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin α9β1-dependent cellular activities. J Biochem 283: 2858-2870.
5. Bazigou E, Xie S, Chen C, Weston A, Miura N, Sorokin L, Adams R, Muro AF, Sheppard D, Makinen T,. 2009. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 17: 175-186.
6. Brideau G, Mäkinen MJ, Elamaa H, Tu H, Nilsson G, Alitalo K, Pihlajaniemi T, Heljasvaara R,. 2007. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res 67: 11528-115235.
7. Eccles S, Paon L, Sleeman JP,. 2007. Lymphatic metastasis: Importance and new insights into cellular and molecule mechanisms. Clin Exp Metastasis 24: 619-636. (Pubitemid 50001146)
8. Friedl P,. 2004. Prespecification and plasticity: Shifting mechanisms of cell migration. Curr Opin Cell Biol 16: 14-23. (Pubitemid 38368147)
9. Fukumoto S, Morifuji M, Katakura Y, Ohishi M, Nakamura S,. 2005. Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells. Clin Exp Metastasis 22: 31-38. (Pubitemid 41185859)
10. Huang X, Wong MK, Zhao Q, Zhu Z, Wang KZ, Huang N, Ye C, Gorelik E, Li M,. 2001. Soluble recombinant endostatin purified from Escherichia coli: Antiangiogenic activity and antitumor effect. Cancer Res 61: 478-481. (Pubitemid 32128601)
11. Karpanen T, Alitalo K,. 2008. Molecule biology and pathology of lymphangiogenesis. Annu Rev Pathol 3: 367-397.
12. Matsuo M, Sakurai H, Koizumi K, Saiki I,. 2007. Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells. Cancer Lett 251: 288-295. (Pubitemid 46669800)
13. Mishima K, Watabe T, Saito A, Yoshimatsu Y, Imaizumi N, Masui S, Hirashima M, Morisada T, Oike Y, Araie M, Niwa H, Kubo H, Suda T, Miyazono K,. 2007. Prox1 Induces lymphatic endothelial differentiation via integrinα9 and other signalling cascades. Mol Biol Cell 18: 1421-1429. (Pubitemid 46626636)
14. Ou JJ, Wu F, Liaug HJ,. 2010. Colorectal tumor derived fibronectin alternatively spliced EDA domain exserts lymphaugiogenic effect on human lymphatic endothelial cells. Cancer Biol Ther 9: 1-6.
15. Rybak JN, Roesli C, Kaspar M, Villa A, Neri D,. 2007. The Extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 67: 10948-10957. (Pubitemid 350145924)
16. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K,. 2004. Lymphatic vasculature: Development, molecule regulation and role in tumor metastasis and inflammation. Trends Immunol 25: 387-395. (Pubitemid 38780956)
17. Schmidt A, Wenzel D, Thorey I, Werner S, Fleischmann BK, Bloch W,. 2005. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: Influence of endostatin on vascular endothelial growth factor (VEGF) signaling. Endothelium 12: 251-257. (Pubitemid 43771809)
18. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M,. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198. (Pubitemid 32148486)
19. Thiele W, Sleeman JP,. 2006. Tumor-induced lymphangiogenesis: A target for cancer therapy? J Biotechnol 124: 224-241. (Pubitemid 43816134)
20. Vlahakis NE, Youug BA, Atakilit A, Sheppard D,. 2005. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin α9β1. J Biol Chem 280: 4544-4552. (Pubitemid 40288622)
21. Wilson RF, Morse MA, Pei P, Renner RJ, Schuller DE, Robertson FM, Mallery SR,. 2003. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Res 23: 1289-1295. (Pubitemid 36754090)
22. Yan Leychkis A, Stephen RM, Jessica LR,. 2009. What is stemness? Stud Hist Philos Biol Biomed Sci 40: 312-320.
23. Zhou W, Luo C, Wang X, Song X, Fu Y, Luo Y,. 2010. Endostatin inhibits tumor lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenenic endothelial cells. J Pathol 222: 249-260.